Medical device company InfraScan has received a green light from the U.S. Food and Drug Administration to market its handheld device to detect bleeding in the brain. The FDA granted approval for the infrascanner to be marketed through a de novo classification process, a regulatory pathway for some low- to moderate-risk medical devices that are […]
When it comes to brain trauma, time is of the essence, or as Infrascan CEO Baruch Ben Dor puts it: time lost is brain lost. A handheld medical device designed to detect bleeding in the brain, the Infrascanner, is designed to be used as a sort of triage device by first responders and physicians to […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.